Bristol Myers Squibb expanding cell manufacturing in Devens

The building will manufacture lymphoma drug Breyanzi, which the FDA approved earlier this year.

Source: bizjournals.com Health Care:Biotechnology headlines - February 25, 2021 Category: Biotechnology Authors: Catherine Carlock Source Type: news